2026 Vir Biotechnology, Inc. 1 VIR-5500 Strategic Collaboration with Astellas and Positive Phase 1 Data February 23, 2026 2026 Vir Biotechnology, Inc. 2 Agenda Legal disclaimer Forward-Looking Statements Statements in this presentation that are not statements of historical fact are forward-looking statements. Such forward-looking statements include, without limitation, statements regarding: the therapeutic and commercial potential of VIR-5500 and other assets within its oncology solid tumor portfolio, precl ...

Core Viewpoint - Pfizer Inc. is hosting a conference call on December 16, 2025, to provide financial guidance for the full year of 2026, inviting both investors and the public to participate [1][2]. Group 1: Conference Call Details - The conference call will take place at 8:00 a.m. EST and will be accessible via a webcast on Pfizer's investor website [1][2]. - Participants are encouraged to register in advance for the conference call, with dial-in options provided for both U.S. and international attendees [2]. - A transcript and replay of the call will be available on Pfizer's website within 24 hours and accessible for at least 90 days [3]. Group 2: Company Overview - Pfizer is committed to applying science and global resources to develop therapies that significantly improve patients' lives, focusing on quality, safety, and value in healthcare products [4]. - The company collaborates with healthcare providers, governments, and communities to enhance access to affordable healthcare worldwide [4]. - Pfizer has a long history of 175 years in the biopharmaceutical industry, emphasizing its role in advancing wellness and combating serious diseases [4].